Manulife (Manufacturers Life Insurance)’s Protalix BioTherapeutics PLX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PLX Stock Details PLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42.4K	Buy	19,528 +1,030	+6%	+$2.56K	﹤0.01%	2758
2025 Q4	$33.3K	Sell	18,498 -5,556	-23%	-$11.4K	﹤0.01%	2844
2025 Q3	$53.4K	Buy	+24,054	New	+$39.2K	﹤0.01%	2877
2024 Q1	–	Sell	-10,514	Closed	-$18.7K	–	2986
2023 Q4	$18.7K	Buy	+10,514	New	+$16.4K	﹤0.01%	2941
2017 Q2	–	Sell	-54	Closed	-$1K	–	4426
2017 Q1	$1K	Hold	54	–	–	﹤0.01%	4063
2016 Q4	$0	Hold	54	–	–	﹤0.01%	4425
2016 Q3	$0	Hold	54	–	–	﹤0.01%	4334
2016 Q2	$0	Hold	54	–	–	﹤0.01%	4311
2016 Q1	$0	Hold	54	–	–	﹤0.01%	4150
2015 Q4	$1	Hold	54	–	–	﹤0.01%	3898
2015 Q3	$1	Hold	54	–	–	﹤0.01%	3934
2015 Q2	$1	Sell	54 -273	-83%	-$5.66K	﹤0.01%	3915
2015 Q1	$6	Hold	327	–	–	﹤0.01%	3650
2014 Q4	$6	Hold	327	–	–	﹤0.01%	3552
2014 Q3	$8	Hold	327	–	–	﹤0.01%	3530
2014 Q2	$12K	Buy	+327	New	+$13.2K	﹤0.01%	3376

Other funds holding PLX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PLX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Protalix BioTherapeutics (PLX) stake by 5.6% in Q1 2026, buying an estimated $2.56K and bringing the position to 19,528 shares worth $42.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2758.

Manulife (Manufacturers Life Insurance) first reported a position in PLX in Q2 2014 and has held it in 16 quarters since. The position peaked at $53.4K in Q3 2025. 100 funds tracked by Wall St. Rank hold PLX as of Q1 2026.

Manulife (Manufacturers Life Insurance) held 19,528 shares of Protalix BioTherapeutics worth $42.4K as of Q1 2026.
Manulife (Manufacturers Life Insurance) bought 1,030 Protalix BioTherapeutics shares in Q1 2026, an estimated $2.56K.
Protalix BioTherapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2758 holding.
Manulife (Manufacturers Life Insurance) first reported a position in Protalix BioTherapeutics in Q2 2014 and has held it in 16 quarters since.
Manulife (Manufacturers Life Insurance)'s Protalix BioTherapeutics position peaked at $53.4K in Q3 2025.
100 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.